Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency

Sarah Aminov(Albert Einstein College of Medicine), Amit Verma(M.J.P. Rohilkhand University), Kith Pradhan(Albert Einstein College of Medicine), Cristian Papazoglu(Albert Einstein College of Medicine), Orsi Giricz(Albert Einstein College of Medicine), Srinivas Aluri(Albert Einstein College of Medicine), Joshua Brody(New York University), Stefan K. Barta(University of Pennsylvania), William Matsui(The University of Texas at Austin), Ioannis Mantzaris(Montefiore Medical Center), Nirali N. Shah(National Institutes of Health), Samir Parekh(The Ohio State University Wexner Medical Center), Bonnie Yates(National Institutes of Health), Violetta V. Leshchenko(Icahn School of Medicine at Mount Sinai), Aditi Shastri(The University of Texas MD Anderson Cancer Center), Carolina Schinke(University of Arkansas for Medical Sciences), Shanisha Gordon-Mitchell(Albert Einstein College of Medicine), Beamon Agarwal(Providence College), David T. Melnekoff(Icahn School of Medicine at Mount Sinai), Ulrich Steidl(Albert Einstein College of Medicine), Mendel Goldfinger(Albert Einstein College of Medicine), Hao‐Wei Wang(Fu Jen Catholic University), Yanhua Wang(Albert Einstein College of Medicine), Moah Sohn(Precision for Medicine (United States)), Veronika Polishchuk(Albert Einstein College of Medicine), Srabani Sahu(Albert Einstein College of Medicine), R. Alejandro Sica
Journal of Clinical Investigation
February 20, 2024
Cited by 20


Related Papers